Etiket: Exscientia
Exscientia reports third quarter 2023 financial results on November 9, 2023
Exscientia plc (Nasdaq: EXAI) will report financial results for the third quarter ended September 30, 2023 on November 9, 2023, prior to the start of U.S. stock markets. At 1:30…
Exscientia: Sixth Molecule Developed via Generative AI Platform Enters Clinical Phase
shares in this article Exscientia plc (Nasdaq: EXAI) announced today that Sumitomo Pharma Co, Ltd. (“Sumitomo Pharma”) announced the initiation of a Phase 1 clinical trial of DSP-2342 in the…
Exscientia Expands Biologics Development Capabilities with Automated Laboratory
shares in this article Exscientia plc (Nasdaq: EXAI) today announced the expansion of its platform to include biologics development, e.g. B. of human antibodies. During the year, the company further…
Michael Krams, MD, joins Exscientia as Chief Quantitative Medicine Officer
shares in this article Exscientia plc (Nasdaq: EXAI) today announced the appointment of Michael Krams, MD, as the Company’s Chief Quantitative Medicine Officer. In this newly created position, Dr. Krams…